Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2028781000168110 | sebelipase alfa (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2028791000168113 | sebelipase alfa | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sebelipase alfa | Is a | medicinal product | true | Inferred relationship | Some | ||
| sebelipase alfa | has intended active ingredient | sebelipase alfa | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| sebelipase alfa 2 mg/mL injection, vial | Is a | False | sebelipase alfa | Inferred relationship | Some | |
| sebelipase alfa 20 mg/10 mL injection, vial | Is a | True | sebelipase alfa | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR